Nonpathogenic intestinal amebae infection epidemiology and demographics
|
Nonpathogenic intestinal amebae infection Microchapters |
|
Differentiating Nonpathogenic intestinal amebae infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nonpathogenic intestinal amebae infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nonpathogenic intestinal amebae infection epidemiology and demographics |
|
FDA on Nonpathogenic intestinal amebae infection epidemiology and demographics |
|
CDC on Nonpathogenic intestinal amebae infection epidemiology and demographics |
|
Nonpathogenic intestinal amebae infection epidemiology and demographics in the news |
|
Blogs on Nonpathogenic intestinal amebae infection epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
The species that are nonpathogenic (Chilomastix mesnili, endolimax nana, entamoeba coli, entamoeba dispar, entamoeba hartmanni, entamoeba polecki, iodamoeba buetschlii) are distributed worldwide. Consequently, infections by these species occur worldwide. Entamoeba polecki in nature is primarily a parasite of pigs and monkeys, and human infection is more prevalent in areas where the people have animal contact.